Jena, Germany — Endress+Hauser (Deutschland) AG Co. KG (“E+H KG”) concluded an option agreement with the founder and Chief Executive Officer of Analytik Jena AG, Klaus Berka, and with the Thüringer Industriebeteiligungs-GmbH & Co. KG (“TIB”) today. Through it, the contract parties have the right to purchase or transfer the shares of Analytik Jena AG […]
PLANEGG, Germany — Biomax Informatics AG will invest nearly 1 million Euro over the next 4 years to transfer its successful systems medicine approach from respiratory and chronic diseases to mental health. The European Commission is co-financing this step with €650,000 as part of the METSY project. In the project, Biomax will provide the knowledge […]
Las Vegas, NV — Station X has created GenePool, a new software platform that allows medical researchers to solve complex biological and clinical problems. The GenePool software-as-a-service platform empowers researchers to analyze large clinical populations and expedite diagnostic development and research into genetic diseases. With GenePool, researchers in Pharma and Biotech companies can shave months […]
LAKEWOOD, Colo. — Terumo BCT has released updated software for the Quantum system as part of its ongoing goal to aid cell therapy companies and research organizations in current Good Manufacturing Practices (cGMP) and compliance with Part 11 of the Code of Federal Regulations (CFR). KEY FACTS ABOUT QUANTUM SOFTWARE 2.0 •Automates traditional manual reporting […]
PHOENIX — Maverix Biomics Inc., today announced at the Association of Molecular Pathology (AMP) 2013 Annual Meeting in Phoenix, Arizona that the company has signed a non-exclusive strategic co-marketing agreement with QIAGEN to streamline the interpretation of raw next-generation sequencing (NGS) data into meaningful and actionable insights. The Maverix Analytic Platform will complement QIAGEN’s sample-to-insight […]
PHOENIX, Arizona; REDWOOD CITY, California; and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has begun enrolling molecular diagnostics laboratories in an Early Access Program to complete the development of a new web-based solution to deliver faster, easier-to-use and high-confidence clinical interpretation and reporting of observed gene variants in […]
LANCASTER, Calif. — Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that WuXi PharmaTech (NYSE:WX), China’s largest contract research organization (CRO), has obtained a multiyear license to ADMET Predictor™, Simulations Plus’ flagship structure-to-property prediction software. John DiBella, vice president of marketing and sales […]
Norwalk, CT. – Cerno Bioscience has today announced a new version of its flagship MassWorks software product. More than any previous improvements and enhancements, the new Version 4 adds DirectRead™ data support for three high resolution MS systems: Thermo Orbitrap or FT ICR MS, Agilent TOF, and Waters TOF, while expanding unit mass resolution direct […]
WASHINGTON –– Speaking at the U.S. News & World Report Hospital of Tomorrow forum Tuesday, Northrop Grumman Corporation’s (NYSE:NOC) Amy Caro, vice president of health IT programs, said advances in genomics and more widespread use of molecular data will enhance healthcare and improve health outcomes but ensuring the security of personal data is key to […]
SAN DIEGO — Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the latest release of its unified biology assay and study management software suite consisting of Accelrys BioRails DM 4.5, Accelrys BioRails PTO 4.5 and Accelrys Morphit 3.0. The Accelrys BioRails assay data management and project tracking/optimization applications […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
